{
  "paper_metadata": {
    "pmid": "23028338",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on BRCA2 variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8297delC",
      "protein_notation": "p.Thr2766Asnfs*11",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 3,
        "demographics": "1 male, 2 females; ages 30-60",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 2,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 66.67,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 60,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The index case in the FANCC c.67delG family developed breast cancer at age 60 but independent clinical testing subsequently identified a deleterious mutation in BRCA2 (c.8297delC, p.Thr2766Asnfs*11) in other breast cancer-affected family members."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The mutation is present in a male diagnosed with breast cancer but not in the youngest affected female relative in the family."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "unaffected",
          "evidence_sentence": "The mutation is present in a male diagnosed with breast cancer but not in the youngest affected female relative in the family."
        }
      ],
      "functional_data": {
        "summary": "The mutation is predicted to cause a frameshift leading to a truncated protein.",
        "assays": []
      },
      "segregation_data": "The mutation co-segregated with breast cancer in the family.",
      "population_frequency": "Not reported in 1000 Genomes data.",
      "evidence_level": "Strong evidence based on segregation and clinical presentation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The BRCA2 mutation was identified in a family previously classified as BRCA1/2 negative.",
      "key_quotes": [
        "The index case in the FANCC c.67delG family developed breast cancer at age 60 but independent clinical testing subsequently identified a deleterious mutation in BRCA2 (c.8297delC, p.Thr2766Asnfs*11) in other breast cancer-affected family members."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.26delC",
      "protein_notation": "p.Pro9Glnfs*16",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "1 female, ages 30-36",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 1,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 50.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 30,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "In family 6, exome sequencing identified a deleterious BRCA2 mutation (c.26delC, p.Pro9Glnfs*16) in a female diagnosed with breast cancer at age 30."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 36,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "unaffected",
          "evidence_sentence": "In family 6, exome sequencing identified a deleterious BRCA2 mutation (c.26delC, p.Pro9Glnfs*16) in a female diagnosed with breast cancer at age 30, but not in her cousin who was diagnosed at age 36."
        }
      ],
      "functional_data": {
        "summary": "The mutation is predicted to cause a frameshift leading to a truncated protein.",
        "assays": []
      },
      "segregation_data": "The mutation co-segregated with breast cancer in the family.",
      "population_frequency": "Not reported in 1000 Genomes data.",
      "evidence_level": "Strong evidence based on segregation and clinical presentation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The BRCA2 mutation was identified in a family previously classified as BRCA1/2 negative.",
      "key_quotes": [
        "In family 6, exome sequencing identified a deleterious BRCA2 mutation (c.26delC, p.Pro9Glnfs*16) in a female diagnosed with breast cancer at age 30, but not in her cousin who was diagnosed at age 36."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}